Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas

Summary

RATIONALE: Current therapies for adults with recurrent or refractory mixed gliomas provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of adults with recurrent or refractory mixed gliomas. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults with recurrent or refractory mixed gliomas.

Timeline

Start

1996-03

Primary completion

2007-08

Completion

2007-08

Drugs

Indications